Order Article Reprints

Haddad F, Mohammed N, Gopalan RC, Ayoub YA, Nasim MT, Assi KH. Development and Optimisation of Inhalable EGCG Nano-Liposomes as a Potential Treatment for Pulmonary Arterial Hypertension by Implementation of the Design of Experiments Approach. Pharmaceutics. 2023; 15(2):539. https://doi.org/10.3390/pharmaceutics15020539

Haddad, Fatma, Nura Mohammed, R. C. Gopalan, Yousef Al Ayoub, Md Talat Nasim, and K. H. Assi. 2023. "Development and Optimisation of Inhalable EGCG Nano-Liposomes as a Potential Treatment for Pulmonary Arterial Hypertension by Implementation of the Design of Experiments Approach" Pharmaceutics 15, no. 2: 539. https://doi.org/10.3390/pharmaceutics15020539

Haddad, F., Mohammed, N., Gopalan, R. C., Ayoub, Y. A., Nasim, M. T., & Assi, K. H. (2023). Development and Optimisation of Inhalable EGCG Nano-Liposomes as a Potential Treatment for Pulmonary Arterial Hypertension by Implementation of the Design of Experiments Approach. Pharmaceutics, 15(2), 539. https://doi.org/10.3390/pharmaceutics15020539